Three controlled trials of weight loss
with phenylpropanolamine
by
Altschuler S, Conte A, Sebok M,
Marlin RL, Winick C.
Int J Obes 1982;6(6):549-56

ABSTRACT

A multisite double-blind study was designed to determine the effectiveness of a phenylpropanolamine-caffeine combination in achieving weight loss. Two-hundred and one obese adult patients were divided into three separate groups in which phenylpropanolamine/caffeine was compared with either placebo (6 weeks), mazindol (6 weeks), or diethylpropion (8 weeks). In these clinical trials, phenylpropanolamine/caffeine proved to be as effective as mazindol and diethylpropion and significantly more effective than placebo in achieving weight loss. Overall, phenylpropanolamine/caffeine had fewer side effects than mazindol and diethylpropion. Its use as an effective anorectic agent in the treatment of obesity is reviewed.

PPA
Adderall
Pregnancy
Neurotoxicity
CNS stimulants
Dopamine uptake
Psychotomimesis
Appetite suppressants
Amphetamine withdrawal/depression
Phenylpropanolamine v pseudoephedrine

HOME

Refs
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?